rs77449037

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000204.5(CFI):​c.*144T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00234 in 799,092 control chromosomes in the GnomAD database, including 24 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0078 ( 15 hom., cov: 33)
Exomes 𝑓: 0.0010 ( 9 hom. )

Consequence

CFI
NM_000204.5 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 1.03

Publications

0 publications found
Variant links:
Genes affected
CFI (HGNC:5394): (complement factor I) This gene encodes a serine proteinase that is essential for regulating the complement cascade. The encoded preproprotein is cleaved to produce both heavy and light chains, which are linked by disulfide bonds to form a heterodimeric glycoprotein. This heterodimer can cleave and inactivate the complement components C4b and C3b, and it prevents the assembly of the C3 and C5 convertase enzymes. Defects in this gene cause complement factor I deficiency, an autosomal recessive disease associated with a susceptibility to pyogenic infections. Mutations in this gene have been associated with a predisposition to atypical hemolytic uremic syndrome, a disease characterized by acute renal failure, microangiopathic hemolytic anemia and thrombocytopenia. Primary glomerulonephritis with immune deposits and age-related macular degeneration are other conditions associated with mutations of this gene. [provided by RefSeq, Dec 2015]
CFI Gene-Disease associations (from GenCC):
  • atypical hemolytic-uremic syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • atypical hemolytic-uremic syndrome with I factor anomaly
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • complement factor I deficiency
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
  • C3 glomerulonephritis
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • Doyne honeycomb retinal dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • age related macular degeneration 13
    Inheritance: Unknown, AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 4-109740749-A-G is Benign according to our data. Variant chr4-109740749-A-G is described in ClinVar as Benign. ClinVar VariationId is 347142.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00784 (1194/152380) while in subpopulation AFR AF = 0.0271 (1128/41594). AF 95% confidence interval is 0.0258. There are 15 homozygotes in GnomAd4. There are 556 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 15 AD,Unknown,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000204.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CFI
NM_000204.5
MANE Select
c.*144T>C
3_prime_UTR
Exon 13 of 13NP_000195.3P05156
CFI
NM_001318057.2
c.*144T>C
3_prime_UTR
Exon 14 of 14NP_001304986.2E7ETH0
CFI
NM_001440986.1
c.*144T>C
3_prime_UTR
Exon 14 of 14NP_001427915.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CFI
ENST00000394634.7
TSL:1 MANE Select
c.*144T>C
3_prime_UTR
Exon 13 of 13ENSP00000378130.2P05156
ENSG00000285330
ENST00000645635.1
c.1534+1742T>C
intron
N/AENSP00000493607.1A0A2R8Y3M9
CFI
ENST00000963332.1
c.*144T>C
3_prime_UTR
Exon 14 of 14ENSP00000633391.1

Frequencies

GnomAD3 genomes
AF:
0.00784
AC:
1193
AN:
152262
Hom.:
15
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0272
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00314
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00718
GnomAD2 exomes
AF:
0.00192
AC:
277
AN:
144520
AF XY:
0.00167
show subpopulations
Gnomad AFR exome
AF:
0.0262
Gnomad AMR exome
AF:
0.00264
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000272
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000118
Gnomad OTH exome
AF:
0.00309
GnomAD4 exome
AF:
0.00104
AC:
673
AN:
646712
Hom.:
9
Cov.:
8
AF XY:
0.000915
AC XY:
315
AN XY:
344116
show subpopulations
African (AFR)
AF:
0.0271
AC:
461
AN:
17006
American (AMR)
AF:
0.00294
AC:
98
AN:
33296
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
20308
East Asian (EAS)
AF:
0.000185
AC:
6
AN:
32382
South Asian (SAS)
AF:
0.0000949
AC:
6
AN:
63196
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
35486
Middle Eastern (MID)
AF:
0.00119
AC:
5
AN:
4202
European-Non Finnish (NFE)
AF:
0.0000417
AC:
17
AN:
407340
Other (OTH)
AF:
0.00239
AC:
80
AN:
33496
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
33
66
99
132
165
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00784
AC:
1194
AN:
152380
Hom.:
15
Cov.:
33
AF XY:
0.00746
AC XY:
556
AN XY:
74528
show subpopulations
African (AFR)
AF:
0.0271
AC:
1128
AN:
41594
American (AMR)
AF:
0.00314
AC:
48
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
68044
Other (OTH)
AF:
0.00710
AC:
15
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
60
121
181
242
302
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00458
Hom.:
0
Bravo
AF:
0.00946
Asia WGS
AF:
0.00173
AC:
6
AN:
3476

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Atypical hemolytic-uremic syndrome with I factor anomaly (1)
-
-
1
CFI-related disorder (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
3.8
DANN
Benign
0.75
PhyloP100
1.0
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs77449037; hg19: chr4-110661905; API